Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
Authors
Discussion
Loading...
Member takes
Implication
Randomized trial examines the relationship between anxiety disorders and major depressive disorder across multiple countries, suggesting key patterns and implications.
Key Points
- To explore the patterns and correlates of comorbid anxiety disorders among individuals with major depressive disorder across various countries.
- Administered epidemiological interviews to 74,045 adults in 27 surveys across 24 countries.
- Assessed DSM-IV major depressive disorder and comorbid anxiety disorders using the WHO Composite International Diagnostic Interview (CIDI).
- Analyzed correlates including age-of-onset and treatment received for depression.
- 45.7% of lifetime MDD respondents had one or more lifetime anxiety disorders; 51.7% for 12-month MDD.
- Respondents with 12-month anxious MDD reported higher severe role impairment (64.4%) compared to non-anxious MDD (46.0%).
- More respondents with 12-month anxious MDD received treatment (68.8%) in high-income countries compared to non-anxious MDD (45.4%).
Cite This Study
Kessler et al. (2015) studied this question.